Prospective, non-interventional, uncontrolled, open-chart, pharmacoepidemiologic study of prescribing patterns for anti-diabetic drugs at tertiary care hospital in Erode

Radhika P.R, Nandha Kumar J., Chetan H. Borkhataria

Abstract


The aim of this study is to determine current prescribing patterns for anti-diabetic drugs adopted by physicians in Erode. The
prospective, non interventional, uncontrolled, open-chart, pharmacoepidemiological study was conducted from January -2007 to April -2007 at a diabetic care centre having 350 diabetic patients. The pattern of prescribing anti-diabetic drugs was recorded along with glycosylated haemoglobin levels, total cholesterol, high-density lipoprotein, low-density lipoprotein, very low-density lipoprotein and triglycerides in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus patients and the values were observed. The prescribing pattern of the oral anti-diabetic drugs shows that out of the various oral anti-diabetic drugs’ available, drugs from only two groups were prescribed. Sulphonylureas, biguanides and combination therapy accounts for 31.43%, 20.28% and 33.71% of prescriptions, respectively, while insulin alone and with OAD’s accounts for 6.28% and 8.29% prescriptions, respectively. Overall,
prescribing trend is away from monotherapy with insulin and sulphonylureas and towards combination therapies.
Key words: Diabetes mellitus, oral anti-diabetic drugs, demographic profile, pharmacoepidemiologic

Full Text:

PDF

References


Kanugo A, Shatuvere A, Samalk. Antibodies to ICA 12 and

GAD65 in patients with NIDDM from Eastern India. Diabetologia

;4:164.

Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE.

Drug related admissions to an Australian Hospital. J Clin Pharm

Ther 1994;19:341-7.

Lesar T. S, Briceland L, Stein D. Factors related to errors in

medication prescribing. J Am Med Assoc 1997;277:341-7.

Skegg DC. Pit falls on pharmaco epidemiology. Br Med J

;32:1171-2.

Goyal P, Sharma G, Baljinderpal, Singh J, Singh J, Kaur Randhawa

G. Prospective, nonintervention, uncontrolled, open-chart,

pharmacoepidemiologic study of prescribing patterns for lipid

lowering drugs at a tertiary care teaching hospital in North India.

Clin Ther 2002;24:12.

Liesenfeld B, Heekeren H, Schade G, Hepp KD. Quality of

documentation in medical reports of diabetic patients. Int J Qual

Health Care 1996;8:537-42.

Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A.Evidence-based nutrition principles and recommendations for the

treatment and prevention of diabetes and related complications

Diabetes Care 2003;26:51.

World Health Organization. How to investigate drug use in Health

Facilities? Geneva, Switzerland: World Health Organization; 1993,

publication no: 1930049.

Don’t loss your nerves Dr. S. M. Sadikor Hon. Endocrinologists,

Jaslok Hospital and Research centre. Mumbai-26.

Wilkes E, Lawton EE. The Diabetic, The hospital and primary care.

J R Coll Gen Pract 1980;30:199-206.

Singh BM, Holland MR, Thorn PA. Metabolic control of diabetes

in general practice clinics: Comparison with a hospital clinic. Br

Med J 1984;289:726-8.

Lebovitz HE. Diabetes: Clinical science in practice. In: Leslie RD,

Robbins DC, editors. New York: Cambridge University Press; 1995.

p. 450-64.

Rockvile MD. Diabetes vital statistics. USA: American Diabetes

Association; 1996.

Harris MI. Diabetes in America National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases.

;2:95-1468.

Kadhe G, Arasan RE. Advances in drug delivery of oral

hypoglycemic agents Special section: Diabetes. Curr Sci

;83:1539-43.

Fulop M, Hoberman HD, Rascoff JH, Bonheim NA, Dreyer NP,

Tannenbaum H. Lactic acidosis in diabetic patients.Arch Intern

Med 1976;136:987.

Zermatten A, Heptner W, Delaloye B, Séchaud R, Felber JP.

Extrapancreatic effect of glibenclamide: stimulation of duodenal

insulin-releasing activity (DIRA) in man. Diabetologia 1977;13:85.

Diabetes control and complication trial research group. N Engl J

Med 1993;329:978-86.

Defronzo RA. Pharmacologic therapy for type 2 diabetes mellitus.

Ann Intern Med 1999;131:281-303.

Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes:

Scientific review. J Am Med Assoc 2002;287:360-72.

Cohen FJ, Neslusan CA, Conklin JE, Song X. Recent antihyperglycemic

prescribing trend for US privately insured patients

with Type 2 Diabetes. Niger J Clin Pract 2004;7:15-20.

Coulston AM, Mandelbaum D, Reaven GM. Dietary management

of nursing home residents with non-insulin-dependent diabetes

mellitus. Am J Clin Nutr 1990;51:67-71.




DOI: http://dx.doi.org/10.22377/ijgp.v3i3.98

Refbacks

  • There are currently no refbacks.